News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Avagliano Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
4
| Avagliano Mark (Chief Business Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 01/05/2023 |
4
| Avagliano Mark (Chief Business Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,600 shares
@ $0
Granted 41,100 options to buy
@ $5.73, valued at
$235.5k
|
|
| 01/05/2022 |
4
| Avagliano Mark (Chief Business Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 12,000 shares
@ $0
Sold 1,445 shares
@ $10.6115, valued at
$15.3k
Granted 53,000 options to buy
@ $10.69, valued at
$566.6k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|